Literature DB >> 10928142

Presence of human beta-defensin-2 in oral squamous cell carcinoma.

N Mizukawa1, K Sawaki, E Yamachika, J Fukunaga, T Ueno, S Takagi, T Sugahara.   

Abstract

The purpose of this study was to demonstrate immunohistochemically the localization and distribution of human beta-defensin-2 (HBD-2), a peptide with antimicrobial activity, in oral carcinoma tissues. Tissue samples were embedded in paraffin, and HBD-2 was immunostained by the streptavidin-biotin coupled peroxidase method. Cancer cells in the cornified region of well differentiated squamous cell carcinomas were stained intensely. Stained cancer cells detected by anti-HBD-2 antibody were scattered among the cells of the non-cornified region.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928142

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Sphingosine kinase-1 is required for toll mediated beta-defensin 2 induction in human oral keratinocytes.

Authors:  Manjunatha R Benakanakere; Jiawei Zhao; Johnah C Galicia; Michael Martin; Denis F Kinane
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

Review 2.  Antimicrobial peptides in the oral environment: expression and function in health and disease.

Authors:  Beverly A Dale; L Page Fredericks
Journal:  Curr Issues Mol Biol       Date:  2005-07       Impact factor: 2.081

3.  The yin and yang of human Beta-defensins in health and disease.

Authors:  Aaron Weinberg; Ge Jin; Scott Sieg; Thomas S McCormick
Journal:  Front Immunol       Date:  2012-10-08       Impact factor: 7.561

4.  ΔNp63 isoform-mediated β-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma.

Authors:  Meggy Suarez-Carmona; Pascale Hubert; Arnaud Gonzalez; Anaelle Duray; Patrick Roncarati; Charlotte Erpicum; Jacques Boniver; Vincent Castronovo; Agnès Noel; Sven Saussez; Olivier Peulen; Philippe Delvenne; Michael Herfs
Journal:  Oncotarget       Date:  2014-04-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.